Find Academic Supervisors

Laura RijnsView profile

Research Fellow

• Biomaterials
• Tissue Engineering
• Supramolecular Chemistry
• +3 more

Laura Rijns is a Postdoctoral Fellow at Stanford University co-advised by Professors Zhenan Bao and Karl Deisseroth, developing innovative (opto)genetic, electrical, and chemical tools for neural modulation in vitro and in vivo. Her work bridges biomaterials engineering with neuroscience to create next-generation platforms for cellular and tissue engineering. Education PhD in Biomedical Engineering, cum laude (2023), Eindhoven University of Technology (TU/e), Netherlands, under Professors Patricia Dankers and E.W. (Bert) Meijer, focusing on supramolecular hydrogels as extracellular matrix mimics for organoid development. MSc in Biomedical Engineering (2019), Eindhoven University of Technology (TU/e), researching supramolecular assemblies in Professor Meijer's laboratory. BSc in Biomedical Engineering (2017), Eindhoven University of Technology (TU/e). Her research centers on designing dynamic supramolecular hydrogels that replicate extracellular matrix complexity to control cellular behavior. Key interests include tunable mechanical properties for mechanobiology studies, ligand presentation strategies for directing cell polarity, and engineering biomaterials for renal organoid development and neural interfaces. She integrates principles from polymer chemistry, cell biology, and bioengineering to create responsive platforms that bridge synthetic materials with biological systems, with particular emphasis on translating fundamental material properties into functional tissue engineering outcomes. Analysis of her 15 most recent publications (2021-2024) reveals a cohesive research trajectory focused on supramolecular hydrogels for tissue engineering. Dominant themes include stress-stiffening mechanics, cell-adhesive motif engineering, and dynamic control of hydrogel-cell interactions. Her work demonstrates consistent innovation in renal tissue models (glomerulogenesis, tubulogenesis) and neural applications, with increasing sophistication in material design—from basic supramolecular polymers to multi-dynamic systems that mimic extracellular complexity. This progression highlights her unique interdisciplinary approach combining biomaterials science with regenerative medicine. No scientific awards were documented in the provided materials. Laura has no listed advisees or grant funding in the available information. She operates within Stanford's collaborative ecosystem, leveraging resources from both Professor Bao's chemical engineering lab (focusing on biomaterials and electronics) and Professor Deisseroth's neuroengineering group (pioneering optogenetics), creating a powerful synergy for developing neural modulation tools.

David PatersonView profile

Professor

• Cardiorespiratory Control
• Autonomic Neuroscience
• Cardiac Neurobiology
• +1 more

David Paterson is Professor of Physiology and Head of the Department of Physiology, Anatomy & Genetics at the University of Oxford, a role he has held since 2016. He is also a Fellow of Merton College, Oxford, and has served in key administrative positions including Deputy Head (Vice Dean) of the Division of Medical Sciences (2008–2016). His leadership spans strategic planning and education policy, contributing to Oxford’s global ranking in Anatomy & Physiology. Paterson’s research focuses on cardiorespiratory control , autonomic neuroscience , and cardiac neurobiology . His Cardiac Neurobiology Research Group investigates neural regulation of the heart in health and disease, with emphasis on hypertension, arrhythmias, and neurocardiac signaling. Key themes include sympathetic neurotransmission, cyclic nucleotide pathways, and bioelectronic interventions for cardiovascular disorders. His recent publications (2020–2025) emphasize translational neurocardiology, exploring molecular mechanisms of sympathetic hyperactivity, stem cell-based disease models, and bioelectronic therapies. Articles consistently address autonomic dysregulation in hypertension, arrhythmia pathophysiology, and innovative diagnostic tools, reflecting interdisciplinary collaboration across physiology, neuroscience, and engineering. Major Awards & Honors: Honorary Doctorates (Otago, UWA), Fellowships (FRSB, FAPS, FPhysiol) Presidency of The Physiological Society (2020–2022) Carl Ludwig Distinguished Award, Brookhart Award Lecture Editorships: Journal of Physiology (2011–2016), Experimental Physiology (2006–2011) Paterson has supervised 27 doctoral students and secured ~£17M in funding, including a British Heart Foundation Centre of Excellence (£8.4M co-PI) and infrastructural grants for the Burdon Sanderson Cardiac Centre. His group leverages molecular, cellular, and whole-organ approaches to advance neurocardiac therapeutics.

Penny Gordon-LarsenView profile

Professor

• Obesity Research
• Cardiometabolic Disease
• Public Health
• +3 more

Penny Gordon-Larsen is the W. R. Kenan, Jr. Distinguished Professor in Nutrition and Vice Chancellor for Research at the University of North Carolina at Chapel Hill (UNC-CH). She has been affiliated with UNC-CH since 1998, joining the faculty in 2002. Her academic roles include leadership in the Gillings School of Global Public Health, where she previously served as Associate Dean for Research and expanded the school’s funding by 61%. As Vice Chancellor for Research, she oversees a $1.12 billion research enterprise, managing interdisciplinary initiatives, infrastructure, and strategic partnerships. Education: BA in Anthropology/Psychology (Tulane, 1989), PhD in Human Biology (University of Pennsylvania, 1997). Research Focus: Obesity, cardiometabolic diseases, and their interactions with environmental, genetic, and behavioral factors. Leads the Obesity Creativity Hub, a transdisciplinary project involving 27 faculty across 16 departments. Her research highlights include NIH-funded studies on obesity’s genetic and societal determinants, with over $23.6M as PI and $49.1M as co-PI. Notable projects include investigating urbanization’s impact on gut microbiota and metabolic health in China, and analyzing disparities in obesity outcomes through the CARDIA study. Publications span over 270 peer-reviewed articles, cited 103,000+ times (h-index 86). Awards include the George A. Bray Founders Award (2020) and leadership roles in The Obesity Society and NIH advisory councils. She also chairs the Obesity Hub, which seeks precision approaches to combat obesity heterogeneity. Labs/Teams: Gordon-Larsen Lab, Obesity Creativity Hub. Grants & Funding: Over $72.7M in NIH grants, leading multi-institutional collaborations.

• Gene Therapy
• Immunotherapy
• Immunobiology
• +5 more

Associate Professor Grant Logan is a Senior Lecturer at the University of Sydney and a Research Scientist at the Children’s Medical Research Institute. He also serves as an Honorary Hospital Scientist at the Children’s Hospital at Westmead, where he develops serological tools to assess gene therapy eligibility. University of Sydney Children’s Medical Research Institute Children’s Hospital at Westmead Logan’s research focuses on the immunobiology of gene therapies using adeno-associated virus (AAV) vectors . His work explores host-vector interactions, pre-existing immunity, and strategies to enhance gene therapy efficacy for autoimmune and rheumatological disorders . He has contributed to understanding AAV vector tolerogenicity and immune modulation. Recent publications highlight his work on AAV vector engineering for liver-specific expression, DNaseI delivery in lupus models, and anti-AAV antibody characterization in spinal muscular atrophy patients. Honorary Hospital Scientist at Children’s Hospital at Westmead Member, Gene Therapy Technical Advisory Committee to Australian Office of the Gene Technology Regulator Collaborations with biotech industry and multiple patents Key grants include: 2024: NHMRC Ideas Grant for AAV bioengineering to escape pre-existing immunity 2022: NHMRC Ideas Grant for pharmaco-genetic autoimmune kidney disease treatment 2020: NHMRC Ideas Grant for anti-capsid immunity in SMA gene therapy

Alexander SchwoererView profile

Professor

• Cardiovascular Physiology
• Cardiac Arrhythmias
• Heart Failure
• +3 more

Prof. Alexander Schwoerer is a faculty member at the University of Hamburg's Faculty of Medicine, affiliated with the Center for Experimental Medicine and the Institute of Cellular and Integrative Physiology. His research focuses on cardiovascular physiology, particularly cardiac arrhythmias, mechanical unloading effects on heart function, and calcium homeostasis. He has developed novel animal models (e.g., heterotopic heart transplantation) to study cardiac remodeling and arrhythmia mechanisms. Schwoerer also contributes to medical education, integrating interdisciplinary approaches in dental and physiological training programs. Leading research on ventricular arrhythmias and calcium signaling dysregulation Expertise in engineered heart tissue models for myocardial repair studies Key publications on nitro-fatty acids' antiarrhythmic effects and genetic influences on arrhythmia susceptibility His work bridges experimental physiology with clinical translation, emphasizing translational research methodologies. He collaborates with teams at the University Heart Center Hamburg (UKE) and the Center for Molecular Neurobiology Hamburg (ZMNH).

Laura M. LechugaView profile

Professor

• Nanophotonics
• Biosensor Technology
• Lab-on-a-Chip Platforms
• +3 more

Prof. Laura M. Lechuga is a Full Professor at the Spanish National Research Council (CSIC) and leads the Nanobiosensors and Bioanalytical Applications Group at the Catalan Institute of Nanoscience and Nanotechnology (ICN2) in Barcelona, Spain. Her research focuses on nanophotonic biosensors, lab-on-a-chip platforms, and their clinical and environmental applications. Key Research Areas: Nanoplasmonic biosensors, silicon nanophotonics, surface biofunctionalization, and point-of-care diagnostics. With over 200 publications, 8 patent families, and 300+ invited talks, she has co-founded two spin-off companies. Her work spans biomedical diagnostics for infections (e.g., SARS-CoV-2, H. pylori) and environmental monitoring, integrating advanced photonics into portable systems. Scientific Distinctions: Recipient of multiple unspecified awards for her contributions to biosensor technology. The ICN2 Nanobiosensors Group, under her leadership, develops technologies for real-time biomarker analysis, including applications in sepsis detection, therapeutic drug monitoring, and autoimmune disease diagnostics.

• Cardiac Physiology
• Cardiovascular Metabolism
• Heart Failure
• +3 more

Craig Lygate is an Associate Professor of Cardiovascular Physiology at the University of Oxford's Division of Cardiovascular Medicine, leading the 'Cardiac Energetics and Integrative Physiology' research group funded by the British Heart Foundation. His work focuses on understanding cardiac energy metabolism's role in health and disease, particularly exploring therapies for ischaemia and heart failure. He heads the Murine Cardiac Phenotyping Laboratory, using clinical techniques like echocardiography and MRI to assess genetically modified models. Education includes a BSc (Hons), MRes in Biological Sciences (University of Manchester), and a PhD in Cardiovascular Physiology (University of Glasgow). His research combines biochemical assays, cell culture, and collaborative approaches such as genomics and metabolomics, with a current emphasis on the creatine transporter and homoarginine's therapeutic potential. Recent articles highlight advancements in nitric oxide delivery systems for cardiovascular applications and the creatine kinase system's role in cardiac energy provision. Collaborations with Chemistry departments target novel treatments for ischaemia-reperfusion injury. No scientific awards are explicitly listed, but his work has been published in high-impact journals like Circulation and Clinical Science . He advises postgraduate researchers (e.g., Hannah Lake) and oversees grants focused on cardiac energetics. His lab integrates translational research, bridging molecular biology with clinical applications, aiming to translate findings into therapeutic strategies for cardiovascular diseases.

Michael GeorgiadesView profile

Assistant Professor

• Computer Networks
• Tactile Internet
• Mobile Edge Computing
• +3 more

Dr. Michael Georgiades is an Assistant Professor at Neapolis University of Pafos, specializing in computer networks. He holds a BEng (First Class Honours) from King’s College London, an MSc from University College London, and a PhD from the University of Surrey. His career includes roles as R&D Manager at Primetel PLC, Research Fellow at the Centre of Communication Systems Research (CCSR), and Systems Development Engineer at INSIG Ltd. He has contributed to EU-funded ICT projects, holds patents, and authored IETF standards. His research focuses on Tactile Internet, Mobile Edge Computing, Vehicular Networks, IoT, and Edge Intelligence. Research Interests: Tactile Internet Mobile Edge Computing Vehicular Networks IoT Edge Intelligence Awards: Nokia Prize for Research Excellence Primetel Awards for Excellence EPSRC and British Council Studentships Publications span cutting-edge topics like adversarial ML attacks on IoT networks, cryptocurrency market analysis, and satellite-backhauled 5G systems. His work bridges theoretical advancements with practical applications in healthcare, agriculture, and transportation systems.

Mhaned OubounytView profile

Researcher

• Single-cell transcriptomics
• Spatial single-cell network analysis
• Gene regulatory networks
• +3 more

Dr. Mhaned Oubounyt is a Postdoctoral Researcher at the University of Hamburg, affiliated with the Computational Systems Biology (CoSy.Bio) group within the Faculty of Mathematics, Informatics and Natural Sciences. His work focuses on developing computational methods for analyzing single-cell and spatial transcriptomics data, particularly in the context of disease mechanisms and drug repurposing. He is actively involved in the NetMap project, advancing dimensionality reduction techniques using differential regulatory networks. Research interests include gene co-expression networks, spatial single-cell analysis, and systems medicine applications. His methodologies bridge computational biology with clinical and agricultural challenges, such as vaccine responses in pregnancy, plant disease resistance, and cardiovascular pathophysiology. Key contributions include the SCANet and Drugst platforms for drug candidate identification and network-based analysis. Publications highlight a strong focus on network biology applications across domains: from immune system modeling to plant stress responses, leveraging single-cell multi-omics integration. His work emphasizes translational research, with implications for personalized medicine and crop improvement. Collaborations span academic and clinical institutions, reflecting his interdisciplinary approach. Current projects aim to enhance predictive modeling of disease progression and therapeutic interventions through systems-level insights.

Mehrdad ArjomandiView profile

Professor

• Environmental Medicine
• Pulmonary Physiology
• Respiratory Disease Mechanisms
• +3 more

Mehrdad Arjomandi, MD, is a Professor of Medicine at the University of California, San Francisco (UCSF), with a joint appointment at the San Francisco VA Health Care System (SFVA). He holds leadership roles as Director of the UCSF Human Exposure Laboratory, Director of the Environmental Medicine Clinic at SFVA, and Director of the SF VA Airborne Hazard Exposure Study Center of Excellence. His research focuses on environmental and occupational exposures contributing to chronic lung diseases, including COPD, asthma, and effects of pollutants like ozone and tobacco smoke. Education: BA in Molecular Biology (UCSD, 1991), MD (Stanford, 1996), Residency in Internal Medicine (UCLA, 1999), Fellowship in Pulmonary & Critical Care (UCSF, 2003). Key Research: Mechanisms of lung injury from airborne hazards, ozone-induced inflammation, and secondhand smoke effects. Studies include SPIROMICS, COPDGene, and VA cohort analyses. Recent work emphasizes cardiopulmonary outcomes in veterans exposed to airborne hazards, machine learning for COPD prognosis, and lung microbiota in COPD. He leads clinical trials evaluating bronchodilators and albuterol efficacy in exposed populations. Grants: Supported by NIH, Flight Attendant Medical Research Institute, VA, and Department of Defense. Awards: 2022 SFVA HeRO Award for clinical excellence and innovation. Labs/Teams: UCSF Human Exposure Lab, SFVA Environmental Medicine Clinic, and VA Airborne Hazard Study Center. Mentors over 30 trainees in translational and clinical research.

Jean-Phillippe CoudercView profile

Professor

• Biomedical Engineering
• Quantitative Electrocardiography
• Ventricular Repolarization Analysis
• +3 more

Dr. Jean-Phillippe Couderc is a Professor in the Department of Medicine (Cardiology) and joint Professor in the Department of Electrical & Computer Engineering at the University of Rochester. He holds a PhD in Biomedical Engineering from the French National Institute of Applied Sciences (1997) and an MBA from the Simon School (2003). His research focuses on quantitative electrocardiography, ventricular repolarization analysis, and cardiac safety analytics. He serves as Chief Technology Officer of iCardiac Technology Inc. and is a member of the editorial board of the Annals of Non-Invasive Electrocardiology . Dr. Couderc has authored/co-authored over 100 publications and holds multiple awards, including the Frost & Sullivan Technology Innovation Award (2006) and the Mirowski-Moss Career Development Award (2003). His work spans computational science, drug safety evaluation, and mHealth technologies for arrhythmia management. He leads federal-funded grants and collaborates with global institutions like the FDA and NIH. Education: PhD, Biomedical Engineering, French National Institute of Applied Sciences (1997) MBA, Simon School of Business (2003) MS, Medical Specialties, France (1994) Key Research Themes: Ventricular repolarization dynamics, ECG signal processing, cardiac safety of non-cardiac drugs, and digital health innovations. Labs/Teams: Heart Research Follow-up Program Laboratory, THEW (Telemetric and Holter ECG Warehouse Initiative).

Berend IsermannView profile

Professor

• Thrombo-inflammation
• Molecular Biology
• Immunology
• +4 more

Professor Berend Isermann is a Professor of Laboratory Medicine at Leipzig University, affiliated with the Faculty of Medicine. He leads research into thrombo-inflammation mechanisms, focusing on molecular pathways linking coagulation and inflammation in diseases such as diabetes, kidney failure, and cardiovascular conditions. His work has earned prestigious recognition, including the ERC Advanced Grant (2024) for a project investigating molecular switches in thrombo-inflammation. Education: Studied medicine at Würzburg (Germany), Bristol (UK), and New Haven (USA). Completed specialist training in internal medicine, endocrinology, and laboratory medicine at Heidelberg University Hospital. Previously held professorships at the Universities of Magdeburg (2011–2019) and Leipzig (2019–present). Research interests center on understanding how thrombo-inflammation drives diseases like preeclampsia, chronic kidney disease, and complications from infections like COVID-19. Key projects include studying tissue factor’s role in inflammation-coagulation cross-talk, microglial-brain interactions in chronic kidney disease, and developing therapies targeting molecular switches. Scientific achievements include discovering tissue factor’s complex with inflammatory regulators, published in high-impact journals, and advancing methods to measure thrombo-inflammatory biomarkers. His interdisciplinary team at Leipzig Medical Center explores therapeutic strategies to control thrombo-inflammation across multiple organ systems. Awards: ERC Advanced Grant (2024) valued at €2.5 million for five years of research into molecular mechanisms of thrombo-inflammation. Grants and collaborations: ERC-funded project involves analyzing molecular switches in heart disease, obesity, and cancer models. His work bridges basic science and clinical translation, with a focus on kidney-brain interactions and diet-based interventions like the green-Mediterranean diet’s epigenetic effects. Labs/Teams: Leads a cross-departmental team at Leipzig University Medical Center integrating immunology, nephrology, and cardiology research. Collaborates on projects involving placental thrombo-inflammation, anticoagulant drug effects, and machine learning applications in diagnostics.

Denise DoolanView profile

Professor

• Molecular Immunology
• Vaccinology
• Infectious Diseases
• +5 more

Professor Denise Doolan is an Affiliate Professor in The University of Queensland's School of Chemistry and Molecular Biosciences and Deputy Director (Research) at the Institute for Molecular Bioscience (IMB). She previously served as Deputy Director of the Australian Institute of Tropical Health and Medicine and Director of the JCU Centre for Molecular Therapeutics. Her research focuses on molecular immunology, vaccine development, and omics-based approaches to combat infectious and chronic diseases, particularly malaria and Epstein-Barr virus (EBV)-related malignancies. She leads cross-disciplinary programs in antigen discovery, host-pathogen immunity, and biomarker development, leveraging genome-based technologies and human disease models. Academic Positions: Affiliate Professor, Deputy Director (IMB), Affiliate of Centre for Superbug Solutions Executive Roles: President of International Society for Vaccines (2021–2023), Member of Australian Medical Research Advisory Board Her research interests include vaccine engineering, systems immunology, and therapeutic development. Key projects involve identifying EBV protein signatures linked to Multiple Sclerosis and malaria immunity profiling using controlled human infection models. She is renowned for her work in malaria immunology and omics-based diagnostics, recognized with Fellowships from the International Society for Vaccines and Australian Society of Parasitology. Recent publications highlight her work on EBV antibody responses in lymphomas, malaria vaccine candidates, and molecular diagnostics for vascular diseases. She actively supervises PhD students in areas like EBV-MS links and malaria systems immunology, supported by grants from NIH, MS Research Australia, and ARC. Scientific Awards: ISV Fellowship (2017), ASP Fellowship (2019) Grants: NIH-funded malaria vaccine projects, EBV-MS diagnostics (MS Research Australia) Her lab collaborates on developing point-of-care tests and next-generation vaccines, emphasizing translational research to address global health challenges.

Mary BarbeView profile

Professor

• Musculoskeletal Disorders
• Neural Plasticity
• Work-Related Injuries
• +7 more

Mary Barbe, PhD, is a Professor at the Lewis Katz School of Medicine at Temple University, with affiliations in multiple research centers: Cardiovascular Sciences, Biomedical Education and Data Science, Neural Sciences, the Center for Substance Abuse Research, and the Comprehensive NeuroAIDS Center. She conducts interdisciplinary research at the intersection of musculoskeletal and neural systems. Her research interests include: Work-related musculoskeletal disorders (WRMDs) and the effects of repetitive and forceful tasks on tissue degeneration and inflammation. Neural plasticity and sensorimotor dysfunction in animal models. Bladder and urethral sphincter reinnervation after spinal cord injury using surgical nerve transfer techniques. Role of fibrosis, inflammation, and aging in bone and connective tissue pathology. Her recent publications show a strong trend in translational research, combining anatomical, physiological, and behavioral assessments in rodent models to understand overuse injuries and neural repair. Her work spans fields such as orthopedics, urology, neuroscience, and rehabilitation science, often involving collaboration with clinical and surgical teams. Her scientific contributions are recognized through consistent publication in high-impact journals, including Journal of Hand Surgery , Neural Plasticity , Life Sciences , and Nature Reviews Urology , with many articles designated as reviews and freely accessible via PMC. Mary Barbe has made significant contributions to mentoring and collaborative research, though specific names of advisees are not listed. She has been continuously funded by major NIH institutes, including NIAMS and NINDS, supporting long-term projects on musculoskeletal injury and neural restoration. She is actively involved in laboratory-based research and collaborates with experts in urology and neuroanatomy. Her lab utilizes advanced techniques such as electrophysiology, neuroanatomical tract tracing, and behavioral assessments to evaluate functional recovery after injury.

Yea-Jen HsuView profile

Academic

• Health Services Research
• Program Evaluation
• Patient Safety
• +7 more

Yea-Jen Hsu is an Associate Research Professor in the Department of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health. She is actively engaged in health services research with a focus on patient safety, quality improvement, and implementation science. Education: PhD, Johns Hopkins Bloomberg School of Public Health, 2011 MHA, National Yang-Ming University, 2003 BS, National Taiwan University, 2001 Dr. Hsu’s research centers on program evaluation and the application of implementation science to improve healthcare delivery. Her work emphasizes enhancing patient safety culture, reducing healthcare-associated infections, and developing innovative models such as integrating buprenorphine into primary care. She employs rigorous quantitative methods to assess interventions and identify success factors. Her recent publications (2024–2025) reflect a strong focus on patient engagement in pain management, hypertension disparities, infection risk modeling, and electronic health record analytics. These works span high-impact journals in medical quality, internal medicine, and infection control, demonstrating interdisciplinary collaboration and relevance to real-world healthcare systems. Scientific Awards: No awards mentioned in the provided text. Dr. Hsu collaborates extensively with national programs such as the CDC’s Prevention Epicenters and contributes to multi-level interventions aimed at systemic healthcare improvements. While no specific grants or advising roles are listed, her leadership in survey development, data evaluation, and collaborative research indicates active involvement in funded projects. She is not affiliated with a named lab or research team, but her network includes key figures in patient safety and health policy at Johns Hopkins and beyond.